Skip to main content

Advertisement

Contact Hugo A. Barrera-Saldaña

From: A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers

Contact corresponding author